Skip to main content

Response Genetics to Triple Sales Force

NEW YORK (GenomeWeb News) – Response Genetics said today that it intends to triple the size of its sales force in response to higher demand for its ResponseDx genetic testing services.
 
The Los Angeles-based firm did not disclose how many salespeople it currently employs.
 
According to Response Genetics, it has sold more than 500 of its ResponseDx: Lung and ResponseDx: Colon tests since their launch in September 2008. It said that sales figures have surpassed the firm’s initial goals. The firm also noted that it is experiencing a reorder rate of more than 90 percent for the PCR-based tests, which are offered through Response Genetics’ CLIA-certified lab and through NeoGenomics Laboratories, which inked a deal in September to offer the tests.
 
Response Genetics said that its sales force had initially focused on the California market, but with an expansion of its staff it plans to begin serving most major national markets.
 

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.